Oxidative stress in IgA nephropathy

Nephron - Clinical Practice

Volumn 116, Issue 3, 2010, Pages

  Coppo, R ^a   Camilla, R ^a   Amore, A ^a   Peruzzi, L ^a  

^a REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

Author keywords

Advanced oxidation protein products; Chronic kidney disease; IgA nephropathy; Oxidative stress; Pathogenesis of IgAN

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; IMMUNOGLOBULIN A1; OXIDIZING AGENT;

CHRONIC KIDNEY DISEASE; DISEASE COURSE; GENETIC POLYMORPHISM; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANTIGEN-ANTIBODY COMPLEX; ANTIOXIDANTS; BLOOD PROTEINS; DISEASE PROGRESSION; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PROTEINURIA; UREMIA;

EID: 77954185635     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317199     Document Type: Short Survey

References (15)

1. D Amico G: Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004; 24: 179-196.
2. Coppo R, Amore A: Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 2004; 65: 1544-1547.
3. Himmelfarb J, McMonagle E: Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 2001; 60: 358-363.
4. Shah SV, Baliga R, Rajapurkar M, Fonseca VA: Oxidants in chronic kidney disease. J Am Soc Nephrol. 2007; 18: 16-28.
5. Liu Y: Advanced oxidation protein products: a causative link between oxidative stress and podocyte depletion. Kidney Int 2009; 76: 1125-1127.
6. Guo ZJ, Niu HX, Hou FF, Zhang L, Fu N, Nagai R, Lu X, Chen BH, Shan YX, Tian JW, Nagaraj RH, Xie D, Zhang X: Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. Antioxid Redox Signal 2008; 10: 1699-1712.
7. Gómez-Guerrero C, González E, Hernando P, Ruiz-Ortega M, Egido J: Interaction of mesangial cells with IgA and IgG immune complexes: a possible mechanism of glomerular injury in IgA nephropathy. Contrib Nephrol. Basel, Karger, 1993, vol 104, pp 127-137.
8. Chen HC, Guh JY, Chang JM, Lai YH: Differential effects of circulating IgA isolated from patients with IgA nephropathy on superoxide and fibronectin production of mesangial cells. Nephron 2001; 88: 211-217.
9. Suzuki D, Miyata T, Saotome N, Horie K, Inagi R, Yasuda Y, Uchida K, Izuhara Y, Yagame M, Sakai H, Kurokawa K: Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol. 1999; 10: 822-32
10. Vas T, Wagner Z, Jenei V, Varga Z, Kovacs T, Wittmann I, Schinzel R, Balla J, Heidland A, Nagy J: Oxidative stress and non-enzymatic glycation in IgA nephropathy Clin Nephrol. 2005; 64: 343-351.
11. Chen JX, Zhou JF, Shen HC: Oxidative stress and damage induced by abnormal free radical reactions and IgA nephropathy. J Zhejiang Univ Sci B 2005; 6: 61-68.
12. Descamps-Latscha B, Witko-Sarsat V, Nguyen- Khoa T, Nguyen AT, Gausson V, Mothu N, Cardoso C, Noël LH, Guérin AP, London GM, Jungers P: Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers. Kidney Int 2004; 66: 1606-1612.
13. Coppo R, Feehally J, Glassock RJ: IgA nephropathy at two score and one. Kidney Int 2010; 77: 181-186.
14. Coppo R, Camilla R, Alfarano A, Balegno S, Mancuso D, Peruzzi L, Amore A, Dal Canton A, Sepe V, Tovo P: Upregulation of the immunoproteasome in peripheral blood mononuclear cells of patients with IgA nephropathy. Kidney Int 2009; 75: 536-541.
15. Chin HJ, Cho HJ, Lee TW, Na KY, Yoon HJ, Chae DW, Kim S, Jeon US, Do JY, Park JW, Yoon KW, Shin YT, Lee KW, Na KR, Cha DR, Kang YS: Progressive REnal disease and Medical Informatics and gEnomics Research (PREMIER) members. J Korean Med Sci 2009; 24(suppl):S30-S37.